CC
ELV icon

Chicago Capital’s Elevance Health ELV Stock Holding History

Chicago Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$936K Sell
2,419
-8
-0.3% -$2.97K 0.02% 212
2026
Q1 		$711K Buy
2,427
+8
+0.3% +$2.63K 0.02% 233
2025
Q4 		$848K Hold
2,419
– – 0.02% 216
2025
Q3 		$782K Buy
2,419
+230
+11% +$71.5K 0.02% 214
2025
Q2 		$851K Buy
2,189
+20
+0.9% +$8.04K 0.02% 200
2025
Q1 		$943K Hold
2,169
– – 0.03% 180
2024
Q4 		$800K Buy
2,169
+145
+7% +$60.7K 0.02% 186
2024
Q3 		$1.05M Sell
2,024
-12
-0.6% -$6.41K 0.03% 160
2024
Q2 		$1.1M Sell
2,036
-4,336
-68% -$2.29M 0.03% 158
2024
Q1 		$3.3M Sell
6,372
-656
-9% -$326K 0.1% 98
2023
Q4 		$3.31M Buy
7,028
+4,986
+244% +$2.31M 0.12% 91
2023
Q3 		$889K Hold
2,042
– – 0.04% 109
2023
Q2 		$907K Hold
2,042
– – 0.04% 111
2023
Q1 		$939K Hold
2,042
– – 0.05% 108
2022
Q4 		$1.05M Hold
2,042
– – 0.06% 104
2022
Q3 		$928K Buy
2,042
+6
+0.3% +$2.87K 0.05% 107
2022
Q2 		$983K Hold
2,036
– – 0.05% 113
2022
Q1 		$1M Hold
2,036
– – 0.04% 120
2021
Q4 		$944K Hold
2,036
– – 0.04% 129
2021
Q3 		$759K Hold
2,036
– – 0.03% 143
2021
Q2 		$777K Hold
2,036
– – 0.03% 140
2021
Q1 		$731K Hold
2,036
– – 0.03% 133
2020
Q4 		$654K Buy
2,036
+36
+2% +$11K 0.03% 143
2020
Q3 		$537K Hold
2,000
– – 0.03% 151
2020
Q2 		$526K Hold
2,000
– – 0.03% 149
2020
Q1 		$454K Hold
2,000
– – 0.04% 140
2019
Q4 		$604K Hold
2,000
– – 0.04% 147
2019
Q3 		$480K Hold
2,000
– – 0.03% 158
2019
Q2 		$564K Hold
2,000
– – 0.04% 149
2019
Q1 		$574K Hold
2,000
– – 0.04% 138
2018
Q4 		$525K Hold
2,000
– – 0.04% 138
2018
Q3 		$548K Hold
2,000
– – 0.04% 143
2018
Q2 		$476K Hold
2,000
– – 0.04% 154
2018
Q1 		$439K Buy
+2,000
New +$470K 0.06% 110

Other funds holding ELV

AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Chicago Capital's ELV Position: Q2 2026 in Review

Chicago Capital reduced its Elevance Health (ELV) stake by 0.33% in Q2 2026, selling an estimated $2.97K and leaving 2,419 shares worth $936K. The position accounts for 0.02% of the portfolio, ranked #212.

Chicago Capital first reported a position in ELV in Q1 2018 and has held it in 34 quarters since. The position peaked at $3.31M in Q4 2023. 637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Chicago Capital held 2,419 shares of Elevance Health worth $936K as of Q2 2026.
  • Chicago Capital sold 8 Elevance Health shares in Q2 2026, an estimated $2.97K.
  • Elevance Health made up 0.02% of Chicago Capital's portfolio in Q2 2026, its #212 holding.
  • Chicago Capital first reported a position in Elevance Health in Q1 2018 and has held it in 34 quarters since.
  • Chicago Capital's Elevance Health position peaked at $3.31M in Q4 2023.
  • 637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Chicago Capital's 13F filing for Q2 2026, filed 28 Jul 2026.